Karuna Therapeutics to Present at the Stifel 2023 CNS Days
23 March 2023 - 9:30PM
Business Wire
Karuna Therapeutics, Inc. (NASDAQ: KRTX), a clinical-stage
biopharmaceutical company driven to create and deliver
transformative medicines for people living with psychiatric and
neurological conditions, today announced that management will
present at the Stifel 2023 CNS Days on Wednesday, March 29, 2023,
at 8:00 a.m. ET.
A live webcast of the presentation will be available on the
Investor Relations page of Karuna’s website at
investors.karunatx.com. A replay of the webcast will also be
archived for up to 30 days on Karuna’s website following the
conference.
About Karuna
Karuna Therapeutics is a clinical-stage biopharmaceutical
company driven to create and deliver transformative medicines for
people living with psychiatric and neurological conditions. At
Karuna, we understand there is a need for differentiated and more
effective treatments that can help patients navigate the challenges
presented by these severe and disabling disorders. Utilizing our
extensive knowledge of neuroscience, we are harnessing the untapped
potential of the brain in pursuit of novel pathways to develop
medicines that make meaningful differences in peoples’ lives. For
more information, please visit www.karunatx.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230323005338/en/
Investors: Alexis Smith +1 (518) 338-8990
asmith@karunatx.com
Media: Bob Josefsberg +1 (646) 734-3584
bjosefsberg@karunatx.com
Karuna Therapeutics (NASDAQ:KRTX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Karuna Therapeutics (NASDAQ:KRTX)
Historical Stock Chart
From Apr 2023 to Apr 2024